FFCP PHASE1:Hg19::chr10:129780357..129780368,+
From FANTOM5_SSTAR
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to: navigation, search
| Short description: | p@chr10:129780357..129780368, + |
|---|---|
| Species: | Human (Homo sapiens) |
| DPI dataset: | Robust |
| TSS-like-by-RIKEN-classifier(Yes/No): | Yes |
| DHS support(Yes/No): | Yes |
| Description: | CAGE_peak_at_chr10:129780357..129780368, + |
| Coexpression cluster: | C2045_hereditary_adult_acute_chronic_Neutrophils_alveolar_testis |
| Association with transcript: | NA |
| EntrezGene: | NA |
| HGNC: | NA |
| UniProt: | NA |
| Genome view: | ZENBU |
View on UCSC genome browser
CAGE Expression
| Sample | p@chr10:129780357..129780368+ |
|---|
0
2
4
6
8
- Click each plot point to find sample in table
Ontology-based sample term enrichment analysis<b>Summary:</b>This analysis has been performed by utilizing wilcoxon rank sum test.When the number of associated cells/tissues are > n , randomly sampled n cells/tissues are used for P value calculation with rank sum test. this process are repeated several times, and the P values are averaged on the log space <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source dataset<br>data
| Ontology term | p-value | n |
|---|---|---|
| anemia | 6.62e-41 | 1 |
| chronic myeloid leukemia | 3.30e-40 | 1 |
| hematopoietic system disease | 3.11e-21 | 2 |
| hematologic cancer | 5.31e-20 | 51 |
| immune system cancer | 5.31e-20 | 51 |
| lymphoma | 5.90e-17 | 10 |
| leukemia | 7.18e-17 | 39 |
| myeloid leukemia | 2.90e-12 | 31 |
| cardiovascular system disease | 2.53e-11 | 4 |
| organ system cancer | 8.63e-08 | 137 |
Showing 1 to 10 of 10 entries